Can This Approach Help? Inside the Latest Research on Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe
Upadacitinib 15 mg and 30 mg single-drug treatment provided rapid and sustained improvement in atopic hand eczema compared with placebo through Week 16 in patients with moderate-to-severe AD.